Arcuate NPY/AgRP in Appetite

📖 Wiki Page

cell1287 wordssynced 2026-04-02

Arcuate Nucleus NPY/AgRP Neurons in Appetite Regulation

...

Arcuate Nucleus NPY/AgRP Neurons in Appetite Regulation

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Arcuate NPY/AgRP in Appetite</th>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4042028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4072017](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4072017)</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:4042028](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)</td>
</tr>
<tr>
<td class="label">Population</td>
<td>Neurotransmitters</td>
</tr>
<tr>
<td class="label">NPY/AgRP neurons</td>
<td>NPY, AgRP, GABA</td>
</tr>
<tr>
<td class="label">POMC neurons</td>
<td>α-MSH, β-endorphin</td>
</tr>
<tr>
<td class="label">Receptor</td>
<td>Distribution</td>
</tr>
<tr>
<td class="label">Y1R</td>
<td>PVN, LHA, cortex</td>
</tr>
<tr>
<td class="label">Y2R</td>
<td>Hypothalamus, hippocampus</td>
</tr>
<tr>
<td class="label">Y4R</td>
<td>Brainstem, gut</td>
</tr>
<tr>
<td class="label">Y5R</td>
<td>Hypothalamus</td>
</tr>
<tr>
<td class="label">MC3R/MC4R</td>
<td>Hypothalamus</td>
</tr>
<tr>
<td class="label">Signal</td>
<td>Effect on NPY/AgRP</td>
</tr>
<tr>
<td class="label">Leptin (↓)</td>
<td>Increase</td>
</tr>
<tr>
<td class="label">Ghrelin (↑)</td>
<td>Increase</td>
</tr>
<tr>
<td class="label">Glucose (↓)</td>
<td>Increase</td>
</tr>
<tr>
<td class="label">Fatty acids (↓)</td>
<td>Increase</td>
</tr>
<tr>
<td class="label">Insulin (↓)</td>
<td>Increase</td>
</tr>
<tr>
<td class="label">Drug Class</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Y1 receptor antagonists</td>
<td>Block NPY orexigenic effects</td>
</tr>
<tr>
<td class="label">Y2 receptor agonists</td>
<td>Inhibit NPY release</td>
</tr>
<tr>
<td class="label">MC4 receptor agonists</td>
<td>Melanocortin activation</td>
</tr>
<tr>
<td class="label">Ghrelin antagonists</td>
<td>Block orexigenic ghrelin</td>
</tr>
<tr>
<td class="label">Leptin analogs</td>
<td>Restore leptin signaling</td>
</tr>
</table>

Overview

Arcuate Npy Agrp In Appetite plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

The arcuate nucleus of the hypothalamus (Arc) contains the primary orexigenic (appetite-stimulating) neurons in the brain: neuropeptide Y (NPY) and agouti-related peptide (AgRP) co-expressing neurons. These cells represent the master regulators of energy homeostasis and are increasingly recognized for their roles in neurodegenerative disease processes[@schwartz2000][@bigio2022]. Their strategic location adjacent to the median eminence, which lacks a complete blood-brain barrier, allows them to sense circulating metabolic signals directly.

Taxonomy & Classification

External Database Links

[Cell Ontology (CL:4042028)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)
[OBO Foundry (CL:4042028)](http://purl.obolibrary.org/obo/CL_4042028)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

Morphology: immature neuron (source: Cell Ontology)
Morphology can be inferred from Cell Ontology classification

External Database Links

[Cell Ontology (CL:4042028)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4042028)
[OBO Foundry (CL:4042028)](http://purl.obolibrary.org/obo/CL_4042028)
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[CellxGene Census](https://cellxgene.cziscience.com/)
[Human Cell Atlas](https://www.humancellatlas.org/)

Introduction

NPY/AgRP neurons constitute approximately 10-15% of neurons in the hypothalamic arcuate nucleus and represent the most potent orexigenic system in the mammalian brain. These neurons integrate hormonal, nutritional, and neural signals to regulate feeding behavior, energy expenditure, and metabolic homeostasis[@schwartz2000]. Beyond their well-established role in appetite regulation, emerging research reveals their involvement in neurodegenerative processes through effects on neuroinflammation, protein aggregation, and cellular metabolism[@bigio2022][@van2019].

The bidirectional relationship between metabolic dysfunction and neurodegeneration has focused attention on NPY/AgRP neurons as potential therapeutic targets for conditions including Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD)[@bigio2022][@kistner2022].

Anatomy and Location

Neuroanatomical Organization

The arcuate nucleus is located in the mediobasal hypothalamus, adjacent to the third ventricle and the median eminence[@schwartz2000]:

Position: Dorsomedial to the ventromedial hypothalamus
Boundary: Lacks complete blood-brain barrier (circumventricular organ)
Subdivisions:
Dorsal Arc (dArc): More medial, POMC-dominated
Ventral Arc (vArc): More lateral, NPY/AgRP-dominated

Neuronal Population

The arcuate nucleus contains two primary neuronal populations with opposing functions[@schwartz2000]:

Connectivity Patterns

NPY/AgRP neurons project to numerous brain regions[@schwartz2000][@betley2015]:

Paraventricular nucleus (PVN): Primary target, inhibits POMC neurons

Lateral hypothalamus (LH): Orexin/neuropeptin neurons

Dorsal vagal complex: Autonomic regulation

Preoptic area: Thermoregulation and sleep

Mesolimbic system: Reward and motivation

Cortical regions: Higher-order feeding control

Molecular Biology

Neuropeptide Expression

Neuropeptide Y (NPY):

36-amino acid peptide belonging to the pancreatic polypeptide family
Binds to Y1, Y2, Y4, and Y5 receptors with different affinities
Most abundant neuropeptide in the mammalian brain
Acts as both neurotransmitter and neurohormone[@tiesjema2009]

Agouti-related peptide (AgRP):

132-amino acid endogenous inverse agonist of melanocortin receptors
Antagonizes MC3R and MC4R (melanocortin receptors)
Unique among neuropeptides as an inverse agonist
Co-released with NPY and GABA[@ollmann1997]

Receptor Expression

Signaling Pathways

Key intracellular cascades in NPY/AgRP neurons:

Leptin signaling: STAT3 phosphorylation via LepR

Insulin signaling: PI3K/Akt pathway

mTOR pathway: Nutrient sensing

AMPK activation: Energy deficit detection

GABAergic output: Synaptic vesicle release[@dietrich2013]

Function in Energy Homeostasis

Orexigenic Mechanisms

NPY/AgRP neurons stimulate feeding through multiple mechanisms[@schwartz2000][@tiesjema2009]:

NPY release: Potent orexigenic signal acting on Y1 and Y5 receptors

AgRP release: Antagonizes melanocortin signaling (MC3/4R)

GABA release: Inhibits POMC neurons and anorexigenic pathways

Synaptic plasticity: Long-term potentiation of orexigenic circuits

Response to Energy State

These neurons sense and respond to metabolic signals[@schwartz2000][@dietrich2013]:

Fasting and Feeding Cycles

Fasting (24-48h): Dramatic increase in NPY/AgRP neuronal activity
Refeeding: Rapid suppression of activity
Chronic overnutrition: Persistent inhibition (leptin resistance in obesity)
Anorexia: Failure of normal suppression[@schwartz2000]

Role in Neurodegenerative Diseases

Alzheimer's Disease (AD)

NPY/AgRP neurons are affected in AD through several mechanisms[@bigio2022][@craft2022]:

Metabolic dysfunction:

Hypothalamic glucose intolerance precedes cognitive decline
NPY expression altered in AD brains
Leptin resistance affects NPY/AgRP regulation

Neuroinflammation:

Chronic inflammation affects hypothalamic neurons
Pro-inflammatory cytokines (IL-1β, TNF-α) modulate NPY/AgRP
[Neuroinflammation](/mechanisms/neuroinflammation)driven anorexia in AD

Therapeutic implications:

Metabolic interventions may protect hypothalamic neurons
Melatonin receptor agonists show promise
Caloric restriction paradigms studied[@craft2022]

Parkinson's Disease (PD)

NPY/AgRP involvement in PD includes[@kistner2022][@poewe2017]:

Metabolic changes:

Weight loss common in PD patients
Dysregulated appetite and autonomic function
NPY alterations in early PD

Dopaminergic interactions:

NPY modulates dopaminergic tone
Nigrostriatal degeneration affects hypothalamic circuits
Appetite dysregulation precedes motor symptoms

Therapeutic considerations:

Levodopa affects feeding behavior
Deep brain stimulation influences hypothalamic pathways
Metabolic monitoring important in PD care

Huntington's Disease (HD)

HD provides unique insights into NPY/AgRP function[@petersen2019]:

Huntingtin mutation affects hypothalamic neurons
NPY system alterations contribute to metabolic symptoms
Early weight loss despite hyperphagia in some HD patients
Autonomic dysfunction involves hypothalamic circuits

Amyotrophic Lateral Sclerosis (ALS)

Metabolic dysfunction in ALS involves hypothalamic mechanisms[@dupuis2019]:

Hypermetabolism common in ALS patients
NPY dysregulation contributes to appetite changes
Respiratory dysfunction affects metabolic state
Bulbar dysfunction affects feeding

Clinical Relevance

Appetite Disorders

NPY/AgRP neurons are central to several clinical conditions[@schwartz2000][@tiesjema2009]:

Obesity:

Elevated NPY/AgRP tone in diet-induced obesity
Leptin resistance uncouples energy sensing
Therapeutic targets: Y1/Y5 antagonists, MC4 agonists

Anorexia nervosa:

Suppressed NPY/AgRP activity
Hyperactivity of anorexigenic pathways
Ghrelin administration shows promise

Binge eating:

Dysregulated NPY/AgRP signaling
Impulsivity and reward pathway involvement
Combined pharmacological approaches needed

Neurodegenerative Disease Management

Metabolic support in neurodegeneration[@kistner2022][@craft2022]:

Nutritional monitoring: Regular weight and appetite assessment
Enteral feeding: When oral intake insufficient
Metabolic interventions: Addressing insulin resistance
Lifestyle modifications: Exercise and dietary approaches

Therapeutic Approaches

Pharmacological Interventions

Emerging Therapies

Optogenetic manipulation: Experimental tool for circuit mapping
Chemogenetic activation/inhibition: DREADD-based approaches
Gene therapy: Targeting NPY/AgRP pathways
Nutraceutical approaches: Dietary interventions[@dietrich2013]
Arcuate Nucleus — Feeding center
NPY/AgRP Neurons — Appetite regulation
Hypothalamus — Energy homeostasis

External Links

[Brain Architecture](https://connectivity.brain-map.org/)

Overview

Background

The study of Arcuate Npy Agrp In Appetite has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

📖 View canonical wiki page →